Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: Evidence of clinical benefit

Epilepsia

Volumn 54, Issue 12, 2013, Pages 2071-2081

  Fosi, Tangunu ^a,b   Lax Pericall, Maria T ^a,c   Scott, Rod C ^a,b   Neville, Brian G ^a,b   Aylett, Sarah E ^a,b  

^a YOUNG EPILEPSY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Attention deficit hyperactivity disorder; Children; Learning disability; Methylphenidate; Refractory epilepsy

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; DEXAMPHETAMINE; ETHOSUXIMIDE; LAMOTRIGINE; MESUXIMIDE; METHYLPHENIDATE; OXCARBAZEPINE; PHENYTOIN; STIRIPENTOL; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; COGNITIVE DEFECT; COMORBIDITY; CORRELATION COEFFICIENT; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; DSM-IV; DYSPHORIA; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; LEARNING DISORDER; LENNOX GASTAUT SYNDROME; LOSS OF APPETITE; MALE; MONOTHERAPY; MYOCLONIC ASTATIC EPILEPSY; OPPOSITIONAL DEFIANT DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; TEMPORAL LOBE EPILEPSY; TREATMENT RESPONSE;

EID: 84890125473     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12399     Document Type: Article

References (61)

1. Abikoff H, Hechtman L, Klein RG, Weiss G,. (2004) Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry 43: 802-811.
2. American Psychiatric Association. (2000) Diagnostic and statistical manual of mental disorders. 4th ed. text rev. American Psychiatric Publishing, Arlington, VA.
3. American Psychiatric Association. (2013) Diagnostic and statistical manual of mental disorders. 5th ed. American Psychiatric Publishing, Arlington, VA.
4. Arroyo S, Brodie MJ, Avanzini G, Baumgartner C, Chiron C, Dulac O, French JA, Serratosa J,. (2002) Is refractory epilepsy preventable. Epilepsia 43: 437-444.
5. Balish M, Albert PS, Theodore WH,. (1991) Seizure frequency in intractable partial epilepsy: a statistical analysis. Epilepsia 32: 642-649.
6. Baptista-Neto L, Dodds A, Rao S, Whitney J, Torres A, Gonzalez-Heydrich J,. (2008) An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy. Expert Opin Investig Drugs 17: 77-84.
7. Barkley RA,. (2003) Issues in the diagnosis of attention-deficit/ hyperactivity disorder in children. Brain Dev 25: 77-83.
8. Bechtel N, Kobel M, Penner IK, Klarhofer M, Scheffler K, Opwis K, Weber P,. (2009) Decreased fractional anisotropy in the middle cerebellar peduncle in children with epilepsy and/or attention deficit/hyperactivity disorder: a preliminary study. Epilepsy Behav 15: 294-298.
9. Besag FM,. (2002) Childhood epilepsy in relation to mental handicap and behavioural disorders. J Child Psychol Psychiatry 43: 103-131.
10. Brignell CM, Rosenthal J, Curran HV,. (2007) Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam. J Psychopharmacol 21: 673-683.
11. Davies S, Heyman I, Goodman R,. (2003) A population survey of mental health problems in children with epilepsy. Dev Med Child Neurol 45: 292-295.
12. Dunn DW, Austin JK, Harezlak J, Ambrosius WT,. (2003) ADHD and epilepsy in childhood. Dev Med Child Neurol 45: 50-54.
13. Engel J,. (2006) Report of the ILAE Classification Core Group. Epilepsia 47: 1558-1568.
14. Faraone SV, Biederman J, Weber W, Russell RL,. (1998) Psychiatric, neuropsychological, and psychosocial features of DSM-IV subtypes of attention-deficit/hyperactivity disorder: results from a clinically referred sample. J Am Acad Child Adolesc Psychiatry 37: 185-193.
15. Goez H, Back-Bennet O, Zelnik N,. (2007) Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder. J Child Neurol 22: 538-542.
16. Gonzalez-Heydrich J, Hsin O, Hickory M, Azeem MW, Mrakotsky C, Torres A, Mezzacappa E, DeMaso DR, Bourgeois B, Biederman J,. (2004) Comparasions of response to stimulant preparation in pediatric epilepsy. Paper presented at the American Academy of Child and Adolescent Psychiatry Meeting, Washington, DC.
17. Gonzalez-Heydrich J, Dodds A, Whitney J, MacMillan C,. (2007) Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder. Epilepsy Behav 10: 384-388.
18. Gonzalez-Heydrich J, Whitney J, Waber D, Forbes P,. (2010) Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy. Epilepsy Behav 18: 229-237.
19. Gross-Tsur V, Manor O, Van Der Meere J, Joseph A, Shalev RS,. (1997) Epilepsy and attention-deficit and hyperactivity disorder: is methylphenidate safe and effective? J Pediatr 130: 670-674.
20. Gucuyener K, Erdemoglu AK, Senol S, Serdaroglu A, Soysal S, Kockar AI,. (2003) Use of methylphenidate for attention-deficit hyperactive disorder in patients with epilepsy or electroencephalographic abnormalities. J Child Neurol 18: 109-112.
21. Hamoda HM, Guild DJ, Gumlak S, Travers BH, Gonzalez-Heydrich J,. (2009) Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations. Expert Rev Neurother 9: 1747-1754.
22. Handen BL, Breaux AM, Gosling A, Ploof DL, Feldman H,. (1990) Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder. Pediatrics 86: 922-930.
23. Handen BL, Feldman H, Gosling A, Breaux AM, McAuliffe S,. (1991) Adverse side-effects of methylphenidate among mentally retarded children with ADHD. J Am Acad Child Adolesc Psychiatry 30: 241-245.
24. Handen BL, Breaux AM, Janosky J, McAuliffe S, Feldman H, Gosling A,. (1992) Effects and noneffects of methylphenidate in children with mental retardation and ADHD. J Am Acad Child Adolesc Psychiatry 31: 455-461.
25. Hemmer SA, Pasternak JF, Zecker SG, Trommer BL,. (2001) Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol 24: 99-102.
26. Hempel AM, Frost MD,. (1995) Factors influencing the incidence of ADHD in pediatric epilepsy patients. Epilepsia 36 (Suppl. 4): 122.
27. Hermann B, Jones J, Dabbs K, Allen CA, Sheth R, Fine J, McMillan A, Seidenberg M,. (2007) The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy. Brain 130: 3135-3148.
28. Hoare P,. (1993) The quality of life of children with chronic epilepsy and their families. Seizure 2: 269-275.
29. Hosain SA, Merchant S, Solomon GE, Chutorian A,. (2006) Topiramate for the treatment of infantile spasms. J Child Neurol 21: 17-19.
30. Kaufmann R, Goldberg-Stern H, Shuper A,. (2009) Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities. J Child Neurol 24: 727-733.
31. Kolk A, Beilmann A, Tomberg T, Napa A, Talvik T,. (2001) Neurocognitive development of children with congenital unilateral brain lesion and epilepsy. Brain Dev 23: 88-96.
32. Koneski JA, Casella EB, Agertt F, Ferreira MG,. (2011) Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review. Epilepsy Behav 21: 228-232.
33. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J,. (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51: 1069-1077.
34. Landis JR, Koch GG,. (1977) The measurement of observer agreement for categorical data. Biometrics 33: 159-174.
35. McLellan A, Davies S, Heyman I, Harding B, Harkness W, Taylor D, Neville BG, Cross JH,. (2005) Psychopathology in children with epilepsy before and after temporal lobe resection. Dev Med Child Neurol 47: 666-672.
36. Mohanraj R, Brodie MJ,. (2006) Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur J Neurol 13: 277-282.
37. MTA Co-Operative Group. (1999) A 14-month randomised controlled trial of treatment strategies for attention deficit hyperactivity disorder: the MTA Co-Operative group Multimodal Treatment study of children with ADHD. Arch Gen Psychiatry 56: 1073-1086.
38. National Institute for Health and Clinical Excellence. (2012) The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. Clinical guideline 137, United Kingdom. http://www.nice.org.uk/Guidance/cg137
39. National Institute for Health and Clinical Excellence (2008) Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. www.nice.org.uk/CG72. Clinical guideline 72, United Kingdom.
40. National Institute of Mental Health (1970) CGI: clinical global impressions. In, Guy W, Bonato RR, (Eds) Manual for the early clinical drug evaluation unit (ECDEU) assessment battery. Revised ed. National Institute of Mental Health 12, Chevy Chase, MD, pp. 1-6.
41. Neville BG,. (1999) Reversible disability associated with epilepsy. Brain Dev 21: 82-85.
42. Parr JA, Ward A, Inman S,. (2003) Current practice in the management of attention-deficit disorder with hyperactivity (ADHD). Child Care Health Dev 29: 215-218.
43. Pujar S, Calvert S, Cortina-Borja M, Chin RF, Smith RA, Cross JH, Das K, Pitt M, Scott RC,. (2010) Statistical Process Control (SPC)- a simple objective method for monitoring seizure frequency and evaluating effectiveness of drug interventions in refractory childhood epilepsy. Epilepsy Res 91: 205-213.
44. Rowland AS, Skipper B, Rabiner DL, Umbach DM, Stallone L, Campbell RA, Hough RL, Naftel AJ, Sandler DP,. (2008) The shifting subtypes of ADHD: classification depends on how symptom reports are combined. J Abnorm Child Psychol 36: 731-743.
45. Sanchez-Carpentero R, Neville BG,. (2003) Attentional ability in children with epilepsy. Epilepsia 44: 1340-1349.
46. Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P,. (2006) Impact of co-morbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Child Care Health Dev 32: 575-583.
47. Semrud-Clikeman M, Wical B,. (1999) Components of attention in children with complex partial seizures with and without ADHD. Epilepsia 40: 211-215.
48. Sherman EMS, Slick D, Connolly MB, Eyrl KL,. (2007) ADHD, neurological correlates and health-related quality of life in severe pediatric epilepsy. Epilepsia 48: 1083-1091.
49. Shrout PE, Fleiss JL,. (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86: 420-428.
50. Simonoff E,. (2003) Children with psychiatric disorders and learning disabilities. BMJ 330: 742-743.
51. Simonoff E, Pickles A, Chadwick O, Gringras P, Wood N, Higgins S, Maney JA, Karia N, Iqbal H, Moore A,.(2006) The Croydon Assessment of Learning Study: prevalence and educational identification of mild mental retardation. J Child Psychol Psychiatry 47: 828-839.
52. Sonuga-Barke EJ, Van Lier P, Swanson JM, Coghill D, Wigal S, Vandenberghe M, Hatch S,. (2008) Heterogeneity in the pharmacodynamics of two long-acting methylphenidate formulations for children with attention deficit/hyperactivity disorder. A growth mixture modelling analysis. Eur Child Adolesc Psychiatry 17: 245-254.
53. Sonuga-Barke EJ, Coghill D, Wigal T, DeBacker M, Swanson J,. (2009) Adverse reactions to methylphenidate treatment for attention-deficit/ hyperactivity disorder: structure and associations with clinical characteristics and symptom control. J Child Adolesc Psychopharmacol 19: 683-690.
54. Steffenburg S, Gillberg C, Steffenburg U,. (1996) Psychiatric disorders in children and adolescents with mental retardation and active epilepsy. Arch Neurol 53: 904-912.
55. Takon I,. (2011) Clinical use of a modified release methylphenidate in the treatment of childhood attention deficit hyperactivity disorder. Ann Gen Psychiatry 10: 25.
56. Tan M, Appleton R,. (2005) Attention deficit and hyperactivity disorder, methylphenidate and epilepsy. Arch Dis Child 90: 57-59.
57. Thome-Souza S, Kuczynski E, Assumpção F Jr, Rzezak P, Fuentes D, Fiore L, Valente KD,.(2004) Which factors may play a pivotal role on determining the type of psychiatric disorder in children and adolescents with epilepsy? Epilepsy Behav 5: 988-994.
58. Thorndike RL, Hagen EP, Sattler JM,. (1986) Stanford-Binet Intelligence Scale. 4th ed. Riverside Publishing, Itasca, IL.
59. Torres AR, Whitney J, Gonzalez-Heydrich J,. (2008) Attention-deficit/ hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy Behav 12: 217-233.
60. Wechsler D,. (1974) Manual for the Wechsler Intelligence Scale for Children-Revised. Psychological Corporation, New York.
61. Weinberg WA, Emslie GJ,. (1991) Attention deficit hyperactivity disorder: the differential diagnosis. J Child Neurol 7 (Suppl): S21-S34.